MILNACIPRAN HYDROCHLORIDE

MILNACIPRAN HYDROCHLORIDE was reported 6009 times

MILNACIPRAN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 METASTATIC LYMPHOMA 14 0.0358
1 BLEPHAROSPASM 83 0.0132
2 MYOFASCIAL PAIN SYNDROME 8 0.0113
3 RHEUMATIC FEVER 42 0.0094
4 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 5 0.0089
5 C-REACTIVE PROTEIN 8 0.0086
6 BIPOLAR II DISORDER 3 0.0083
7 FACET JOINT SYNDROME 27 0.0083
8 ENDOMETRIAL ADENOCARCINOMA 5 0.0079
9 SWOLLEN JOINT COUNT INCREASED 25 0.0078
10 X-RAY ABNORMAL 14 0.0078
11 DEEP VEIN THROMBOSIS POSTOPERATIVE 15 0.0075
12 LUPUS VULGARIS 9 0.0071
13 URINARY HESITATION 17 0.0071
14 SPONDYLOARTHROPATHY 4 0.0067
15 RAYNAUD'S PHENOMENON 6 0.0064
16 PERIPHERAL VENOUS DISEASE 26 0.0064
17 FIBROMYALGIA 154 0.0063
18 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 13 0.0063
19 ORGASM ABNORMAL 5 0.0062
20 ANAEMIA VITAMIN B12 DEFICIENCY 3 0.0061
21 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 8 0.0059
22 RELAPSING-REMITTING MULTIPLE SCLEROSIS 5 0.0058
23 PRE-EXISTING CONDITION IMPROVED 36 0.0058
24 ONYCHOMADESIS 24 0.0057
25 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 6 0.0056
26 ALCOHOL INTOLERANCE 4 0.0056
27 DISSOCIATIVE DISORDER 4 0.0055
28 PILOERECTION 6 0.0055
29 DISLOCATION OF VERTEBRA 12 0.0053
30 HYPOPARATHYROIDISM 4 0.0052
31 CARTILAGE ATROPHY 4 0.0050
32 BLOOD OSMOLARITY DECREASED 3 0.0048
33 INFUSION SITE REACTION 14 0.0047
34 REBOUND ACID HYPERSECRETION 14 0.0046
35 RHEUMATOID FACTOR POSITIVE 26 0.0045
36 TESTICULAR PAIN 14 0.0044
37 ARTHROSCOPY 3 0.0044
38 RETINITIS 7 0.0040
39 FRACTURED SACRUM 5 0.0040
40 BUTTERFLY RASH 4 0.0039
41 DUODENAL ULCER PERFORATION 29 0.0039
42 INTERVERTEBRAL DISC COMPRESSION 4 0.0038
43 TASTE DISORDER 77 0.0038
44 NARCOLEPSY 7 0.0037
45 ALTERED VISUAL DEPTH PERCEPTION 3 0.0037
46 DRY AGE-RELATED MACULAR DEGENERATION 4 0.0036
47 BREAST CANCER STAGE III 23 0.0035
48 PORPHYRIA ACUTE 5 0.0035
49 WOUND INFECTION STAPHYLOCOCCAL 6 0.0035
50 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 24 0.0033
51 SEROTONIN SYNDROME 64 0.0033
52 ABULIA 3 0.0032
53 BURSITIS 39 0.0032
54 HOMICIDAL IDEATION 13 0.0032
55 BONE EROSION 11 0.0031
56 LIVE BIRTH 25 0.0030
57 CERVICAL SPINAL STENOSIS 5 0.0029
58 EJACULATION DISORDER 8 0.0028
59 TENSION HEADACHE 12 0.0028
60 WOUND INFECTION 30 0.0027
61 ESSENTIAL HYPERTENSION 5 0.0027
62 DRUG DOSE TITRATION NOT PERFORMED 5 0.0027
63 NECK INJURY 8 0.0027
64 SPINAL FUSION SURGERY 11 0.0027
65 COMPLEX REGIONAL PAIN SYNDROME 4 0.0027
66 BACK INJURY 29 0.0027
67 EPICONDYLITIS 4 0.0026
68 MYOCLONIC EPILEPSY 4 0.0026
69 ATROPHY 5 0.0026
70 ALLODYNIA 3 0.0026
71 EPILEPSY 78 0.0025
72 TINEA PEDIS 4 0.0025
73 FOLLICULITIS 26 0.0025
74 BLADDER PROLAPSE 3 0.0025
75 MITRAL VALVE PROLAPSE 4 0.0024
76 PLANTAR FASCIITIS 8 0.0024
77 HOSTILITY 6 0.0024
78 DEAFNESS BILATERAL 4 0.0024
79 INTERVERTEBRAL DISC DISORDER 10 0.0023
80 C-REACTIVE PROTEIN ABNORMAL 15 0.0023
81 HYPERCHOLESTEROLAEMIA 22 0.0023
82 MACULOPATHY 8 0.0023
83 TEMPOROMANDIBULAR JOINT SYNDROME 6 0.0022
84 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 5 0.0022
85 HYPERHIDROSIS 288 0.0022
86 SYNOVITIS 40 0.0022
87 MIGRAINE 210 0.0022
88 RED BLOOD CELL SEDIMENTATION RATE INCREASED 24 0.0022
89 APHTHOUS STOMATITIS 5 0.0022
90 BREAKTHROUGH PAIN 5 0.0022
91 CHRONIC FATIGUE SYNDROME 3 0.0022
92 LYMPH NODE PAIN 4 0.0021
93 HYPERACUSIS 8 0.0021
94 DRUG TOLERANCE DECREASED 6 0.0021
95 SACROILIITIS 4 0.0021
96 SCOLIOSIS 13 0.0021
97 SLEEP APNOEA SYNDROME 40 0.0021
98 URINE FLOW DECREASED 5 0.0021
99 LONG QT SYNDROME 5 0.0021
100 EXOSTOSIS 19 0.0021
101 PEMPHIGUS 26 0.0021
102 CRYING 75 0.0021
103 LUMBAR SPINAL STENOSIS 6 0.0021
104 ONYCHOMYCOSIS 9 0.0020
105 PUSTULAR PSORIASIS 7 0.0020
106 PERICARDITIS 34 0.0020
107 MICTURITION DISORDER 7 0.0020
108 DEPRESSIVE SYMPTOM 7 0.0020
109 SUICIDAL IDEATION 181 0.0020
110 AGE-RELATED MACULAR DEGENERATION 3 0.0020
111 VITAMIN B12 DEFICIENCY 8 0.0020
112 NAIL DISORDER 17 0.0019
113 MUSCLE INJURY 16 0.0019
114 NIGHT SWEATS 62 0.0019
115 HOT FLUSH 142 0.0019
116 ABDOMINAL MASS 5 0.0019
117 MULTIPLE DRUG OVERDOSE INTENTIONAL 6 0.0019
118 COSTOCHONDRITIS 3 0.0018
119 IRRITABLE BOWEL SYNDROME 39 0.0018
120 ANXIETY DISORDER 6 0.0018
121 JOINT RANGE OF MOTION DECREASED 24 0.0018
122 GASTROOESOPHAGEAL REFLUX DISEASE 143 0.0018
123 NEPHROGENIC ANAEMIA 8 0.0017
124 NECK SURGERY 4 0.0017
125 AUTONOMIC NERVOUS SYSTEM IMBALANCE 5 0.0017
126 DECREASED INTEREST 10 0.0017
127 SPINAL COLUMN STENOSIS 8 0.0017
128 SOMNAMBULISM 11 0.0017
129 HEART RATE INCREASED 166 0.0017
130 RASH VESICULAR 8 0.0017
131 HELICOBACTER INFECTION 17 0.0017
132 LUPUS-LIKE SYNDROME 15 0.0017
133 LIP DRY 15 0.0016
134 AUTOIMMUNE DISORDER 16 0.0016
135 FEELING JITTERY 31 0.0016
136 TENDON INJURY 6 0.0016
137 SYSTEMIC LUPUS ERYTHEMATOSUS 57 0.0016
138 HYPERPARATHYROIDISM SECONDARY 4 0.0016
139 GRIP STRENGTH DECREASED 14 0.0016
140 SNORING 6 0.0016
141 DYSURIA 58 0.0016
142 ANGER 53 0.0016
143 OSTEOARTHRITIS 66 0.0016
144 SOCIAL AVOIDANT BEHAVIOUR 9 0.0016
145 PANIC DISORDER 6 0.0015
146 ADRENOCORTICAL INSUFFICIENCY ACUTE 3 0.0015
147 OEDEMA MOUTH 5 0.0015
148 NYSTAGMUS 8 0.0015
149 LYME DISEASE 5 0.0015
150 PALPITATIONS 169 0.0014
151 ELECTRIC SHOCK SENSATION 4 0.0014
152 INTERVERTEBRAL DISC DEGENERATION 13 0.0014
153 OBESITY 22 0.0014
154 SPONDYLITIS 5 0.0014
155 HAND DEFORMITY 18 0.0014
156 BLOOD PRESSURE INCREASED 209 0.0014
157 FOOD INTOLERANCE 5 0.0014
158 ACCIDENT AT WORK 3 0.0014
159 THORACIC VERTEBRAL FRACTURE 4 0.0014
160 URINARY RETENTION 45 0.0013
161 FEELING DRUNK 10 0.0013
162 FACIAL PAIN 12 0.0013
163 VITAMIN D DEFICIENCY 13 0.0013
164 METABOLIC ENCEPHALOPATHY 4 0.0013
165 IMPULSIVE BEHAVIOUR 5 0.0013
166 DEPRESSION 301 0.0013
167 IMPAIRED GASTRIC EMPTYING 18 0.0013
168 PROSTATITIS 4 0.0013
169 JOINT EFFUSION 9 0.0013
170 MENISCUS INJURY 8 0.0013
171 NERVE COMPRESSION 12 0.0013
172 OESOPHAGEAL DISORDER 5 0.0013
173 STRESS FRACTURE 7 0.0013
174 IRRITABILITY 78 0.0013
175 FOOD ALLERGY 10 0.0013
176 BACK DISORDER 21 0.0013
177 FEELING OF DESPAIR 6 0.0013
178 INTERVERTEBRAL DISC PROTRUSION 28 0.0013
179 NECK PAIN 71 0.0013
180 DRUG EFFECT INCREASED 4 0.0013
181 WITHDRAWAL SYNDROME 53 0.0013
182 SCIATICA 20 0.0013
183 WOUND 35 0.0013
184 SPINAL OSTEOARTHRITIS 11 0.0013
185 MEMORY IMPAIRMENT 171 0.0012
186 WEIGHT FLUCTUATION 13 0.0012
187 PRESCRIBED OVERDOSE 24 0.0012
188 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 21 0.0012
189 INSOMNIA 329 0.0012
190 DERMAL CYST 3 0.0012
191 DRY MOUTH 99 0.0012
192 HYPERAESTHESIA 10 0.0012
193 CARTILAGE INJURY 3 0.0012
194 WALKING AID USER 8 0.0012
195 PEPTIC ULCER 4 0.0012
196 DERMATITIS EXFOLIATIVE 6 0.0012
197 EXCORIATION 3 0.0012
198 PANIC ATTACK 43 0.0012
199 NERVE INJURY 13 0.0012
200 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 12 0.0012
201 CONCUSSION 9 0.0012
202 DRUG TITRATION ERROR 3 0.0012
203 CERVICAL VERTEBRAL FRACTURE 4 0.0012
204 AFFECT LABILITY 11 0.0011
205 SPINAL OPERATION 14 0.0011
206 PSORIATIC ARTHROPATHY 46 0.0011
207 LIGAMENT RUPTURE 5 0.0011
208 NIGHTMARE 39 0.0011
209 WHEELCHAIR USER 5 0.0011
210 RHINITIS ALLERGIC 5 0.0011
211 COELIAC DISEASE 11 0.0011
212 GASTROINTESTINAL MOTILITY DISORDER 6 0.0011
213 FRUSTRATION 4 0.0011
214 APPARENT DEATH 4 0.0011
215 PANIC REACTION 8 0.0011
216 BLADDER DISORDER 11 0.0011
217 DRUG INTOLERANCE 107 0.0011
218 BIPOLAR DISORDER 12 0.0011
219 CLUMSINESS 3 0.0011
220 INJECTION SITE PAPULE 5 0.0011
221 PERIPHERAL COLDNESS 15 0.0011
222 CONTRAINDICATED PRODUCT ADMINISTERED 33 0.0011
223 HYPOAESTHESIA 163 0.0011
224 HYPOMANIA 4 0.0011
225 PARAESTHESIA 171 0.0011
226 DRUG SCREEN FALSE POSITIVE 3 0.0011
227 BREAST CANCER STAGE II 9 0.0011
228 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 7 0.0011
229 FEELING COLD 30 0.0011
230 IMPAIRED WORK ABILITY 23 0.0011
231 AGITATION 79 0.0011
232 NEURODERMATITIS 4 0.0011
233 TEMPERATURE INTOLERANCE 11 0.0011
234 BLOOD CHOLESTEROL INCREASED 49 0.0011
235 HAIR TEXTURE ABNORMAL 14 0.0010
236 JOINT DISLOCATION 11 0.0010
237 SLEEP DISORDER 73 0.0010
238 FINGER DEFORMITY 5 0.0010
239 NEURALGIA 25 0.0010
240 MOOD ALTERED 28 0.0010
241 THERAPEUTIC RESPONSE UNEXPECTED 46 0.0010
242 FLUSHING 104 0.0010
243 URINE ODOUR ABNORMAL 6 0.0010
244 PRODUCT ADMINISTRATION INTERRUPTED 8 0.0010
245 ROTATOR CUFF SYNDROME 13 0.0010
246 MYOSITIS 9 0.0010
247 RESPIRATORY DISORDER 30 0.0010
248 MIOSIS 8 0.0010
249 TRIGEMINAL NEURALGIA 4 0.0010
250 ENURESIS 4 0.0010
251 RESTLESS LEGS SYNDROME 18 0.0010
252 LOWER LIMB FRACTURE 19 0.0010
253 INFLAMMATION 51 0.0010
254 MUSCLE TIGHTNESS 16 0.0010
255 GAIT INABILITY 33 0.0010
256 CHRONIC KIDNEY DISEASE 75 0.0010
257 GLOSSODYNIA 22 0.0010
258 TRIGGER FINGER 4 0.0010
259 DYSAESTHESIA 3 0.0010
260 EAR INFECTION 26 0.0010
261 EUPHORIC MOOD 10 0.0010
262 PHARYNGEAL OEDEMA 15 0.0010
263 DIASTOLIC DYSFUNCTION 3 0.0010
264 MIDDLE INSOMNIA 18 0.0010
265 THYROID FUNCTION TEST ABNORMAL 4 0.0010
266 ABDOMINAL PAIN UPPER 198 0.0010
267 DISABILITY 19 0.0010
268 BLOOD BLISTER 3 0.0010
269 TENDERNESS 10 0.0010
270 STOMATITIS 58 0.0010
271 MUSCULOSKELETAL PAIN 50 0.0010
272 TYPE 2 DIABETES MELLITUS 32 0.0009
273 FOOD CRAVING 5 0.0009
274 MENTAL IMPAIRMENT 23 0.0009
275 BLADDER PAIN 3 0.0009
276 SCREAMING 6 0.0009
277 ANXIETY 268 0.0009
278 BODY HEIGHT DECREASED 10 0.0009
279 CUSHINGOID 3 0.0009
280 CARPAL TUNNEL SYNDROME 13 0.0009
281 CARDIAC FLUTTER 6 0.0009
282 BRUXISM 5 0.0009
283 DISTURBANCE IN ATTENTION 50 0.0009
284 TENDON DISORDER 6 0.0009
285 MUSCLE RIGIDITY 11 0.0009
286 SINUS TACHYCARDIA 13 0.0009
287 IMPAIRED HEALING 30 0.0009
288 BEDRIDDEN 12 0.0009
289 FAECALOMA 5 0.0009
290 DYSPHEMIA 4 0.0009
291 ACTIVITIES OF DAILY LIVING IMPAIRED 18 0.0009
292 C-REACTIVE PROTEIN INCREASED 33 0.0009
293 AMNESIA 59 0.0009
294 HEPATIC CIRRHOSIS 17 0.0009
295 ANKLE FRACTURE 14 0.0009
296 MOVEMENT DISORDER 29 0.0009
297 CATHETERISATION CARDIAC 4 0.0009
298 POST-TRAUMATIC STRESS DISORDER 6 0.0009
299 IRON DEFICIENCY 4 0.0009
300 HYPOTHERMIA 9 0.0009
301 ULCER HAEMORRHAGE 6 0.0009
302 NAUSEA 699 0.0009
303 PERONEAL NERVE PALSY 5 0.0009
304 IMPAIRED DRIVING ABILITY 10 0.0009
305 EAR PAIN 17 0.0009
306 OBSESSIVE-COMPULSIVE DISORDER 7 0.0009
307 EYE OPERATION 4 0.0009
308 BLOOD PRESSURE DIASTOLIC INCREASED 4 0.0009
309 BLOOD CHOLESTEROL ABNORMAL 4 0.0009
310 ARTHRITIS INFECTIVE 4 0.0009
311 NERVOUSNESS 45 0.0009
312 THINKING ABNORMAL 16 0.0009
313 ROSACEA 4 0.0009
314 TACHYCARDIA 76 0.0009
315 SWELLING 80 0.0009
316 COLD SWEAT 15 0.0009
317 PAIN 522 0.0008
318 HIATUS HERNIA 11 0.0008
319 TREMOR 140 0.0008
320 ATAXIA 10 0.0008
321 SINUS HEADACHE 5 0.0008
322 SINUSITIS 86 0.0008
323 HEREDITARY ANGIOEDEMA 9 0.0008
324 HYPOVOLAEMIC SHOCK 4 0.0008
325 APHAGIA 4 0.0008
326 TONGUE DISORDER 6 0.0008
327 APATHY 12 0.0008
328 END STAGE RENAL DISEASE 15 0.0008
329 TENSION 5 0.0008
330 VITAMIN D DECREASED 7 0.0008
331 KIDNEY INFECTION 16 0.0008
332 FEELING ABNORMAL 195 0.0008
333 FOOT DEFORMITY 9 0.0008
334 DIABETIC NEUROPATHY 4 0.0008
335 TINNITUS 37 0.0008
336 INFUSION SITE EXTRAVASATION 5 0.0008
337 BLISTER 45 0.0008
338 CENTRAL NERVOUS SYSTEM LESION 11 0.0008
339 JOINT STIFFNESS 21 0.0008
340 CHRONIC SINUSITIS 3 0.0008
341 WRONG TECHNIQUE IN DRUG USAGE PROCESS 29 0.0008
342 PAROSMIA 6 0.0008
343 UNEVALUABLE EVENT 60 0.0008
344 RHEUMATOID ARTHRITIS 90 0.0008
345 PHOTOPSIA 5 0.0008
346 DYSPHORIA 4 0.0008
347 MICTURITION URGENCY 9 0.0008
348 PHOTOSENSITIVITY REACTION 13 0.0008
349 HIP ARTHROPLASTY 12 0.0008
350 FEELING HOT 48 0.0008
351 THERAPEUTIC PRODUCT EFFECT DECREASED 35 0.0008
352 GASTROINTESTINAL INFECTION 7 0.0008
353 MUSCLE TWITCHING 18 0.0008
354 FEMORAL NECK FRACTURE 4 0.0008
355 HEADACHE 489 0.0008
356 OSTEOPOROSIS 32 0.0008
357 INCOHERENT 5 0.0008
358 POOR QUALITY DRUG ADMINISTERED 5 0.0008
359 VOMITING 363 0.0008
360 CONTUSION 74 0.0008
361 MALABSORPTION 4 0.0008
362 ROAD TRAFFIC ACCIDENT 32 0.0008
363 AFFECTIVE DISORDER 6 0.0008
364 CONFUSIONAL STATE 122 0.0008
365 RENAL PAIN 8 0.0008
366 BLOOD PRESSURE ABNORMAL 15 0.0008
367 MOOD SWINGS 24 0.0008
368 EMOTIONAL DISORDER 23 0.0007
369 LACERATION 7 0.0007
370 POOR QUALITY SLEEP 16 0.0007
371 FOOT FRACTURE 14 0.0007
372 APPLICATION SITE DISCOLOURATION 3 0.0007
373 NO THERAPEUTIC RESPONSE 9 0.0007
374 POST PROCEDURAL INFECTION 6 0.0007
375 HYPERTENSION 156 0.0007
376 NORMAL NEWBORN 4 0.0007
377 JAW DISORDER 4 0.0007
378 ABASIA 18 0.0007
379 VISION BLURRED 100 0.0007
380 ONYCHOCLASIS 5 0.0007
381 SPINAL COMPRESSION FRACTURE 6 0.0007
382 CHOKING SENSATION 4 0.0007
383 WHEEZING 43 0.0007
384 ABNORMAL DREAMS 20 0.0007
385 LYMPHOEDEMA 5 0.0007
386 LIP SWELLING 24 0.0007
387 CONGESTIVE CARDIOMYOPATHY 3 0.0007
388 HYPERTENSIVE CRISIS 8 0.0007
389 FORMICATION 5 0.0007
390 HEART RATE ABNORMAL 4 0.0007
391 APHONIA 10 0.0007
392 PRODUCT LEAKAGE 4 0.0007
393 SUICIDE ATTEMPT 43 0.0007
394 URINARY INCONTINENCE 21 0.0007
395 LIGAMENT SPRAIN 7 0.0007
396 SEASONAL ALLERGY 10 0.0007
397 CONSTIPATION 154 0.0007
398 WEIGHT INCREASED 158 0.0007
399 HEPATIC ENZYME INCREASED 48 0.0007
400 PRESCRIBED UNDERDOSE 14 0.0007
401 ARTHROPATHY 39 0.0007
402 DERMATITIS CONTACT 8 0.0007
403 CHOLECYSTECTOMY 8 0.0007
404 EMPHYSEMA 7 0.0007
405 DIZZINESS 343 0.0007
406 PRODUCT LABEL CONFUSION 4 0.0007
407 CHEST PAIN 127 0.0007
408 SENSORY DISTURBANCE 11 0.0007
409 MAJOR DEPRESSION 5 0.0007
410 IMMUNE SYSTEM DISORDER 9 0.0007
411 HALLUCINATION 51 0.0007
412 MUSCLE SPASMS 124 0.0007
413 BLOOD IRON DECREASED 8 0.0007
414 PLEURISY 4 0.0007
415 RENAL INJURY 20 0.0007
416 MUSCULAR WEAKNESS 76 0.0007
417 GENERAL SYMPTOM 5 0.0007
418 HEAD INJURY 21 0.0007
419 ARTHRITIS 52 0.0007
420 OSTEOPENIA 10 0.0007
421 ACUTE HEPATIC FAILURE 9 0.0007
422 RESTLESSNESS 24 0.0007
423 LIVER FUNCTION TEST INCREASED 14 0.0007
424 LIVER INJURY 16 0.0007
425 GRAND MAL CONVULSION 6 0.0006
426 BRONCHITIS 48 0.0006
427 BALANCE DISORDER 56 0.0006
428 CONGENITAL ANOMALY 5 0.0006
429 SCAR 11 0.0006
430 APNOEA 5 0.0006
431 BURNING SENSATION 45 0.0006
432 TUBULOINTERSTITIAL NEPHRITIS 12 0.0006
433 EPSTEIN-BARR VIRUS INFECTION 4 0.0006
434 BRAIN FOG 10 0.0006
435 PHOTOPHOBIA 12 0.0006
436 SWELLING OF EYELID 4 0.0006
437 DRUG SCREEN POSITIVE 5 0.0006
438 ENDOMETRIOSIS 3 0.0006
439 PULMONARY FIBROSIS 12 0.0006
440 MYDRIASIS 8 0.0006
441 GLAUCOMA 12 0.0006
442 HEAD DISCOMFORT 11 0.0006
443 DRUG ERUPTION 11 0.0006
444 MUSCLE DISORDER 5 0.0006
445 HEPATITIS ACUTE 4 0.0006
446 HAEMORRHOIDS 12 0.0006
447 URTICARIA 103 0.0006
448 CONVULSION 35 0.0006
449 RETCHING 13 0.0006
450 JOINT INJURY 13 0.0006
451 ABDOMINAL DISCOMFORT 102 0.0006
452 MANIA 10 0.0006
453 HAIR DISORDER 5 0.0006
454 DELIRIUM 21 0.0006
455 ACUTE CORONARY SYNDROME 5 0.0006
456 INJURY 42 0.0006
457 QUALITY OF LIFE DECREASED 8 0.0006
458 APHASIA 18 0.0006
459 MUSCULOSKELETAL STIFFNESS 52 0.0006
460 DRUG TOLERANCE 3 0.0006
461 COLITIS ISCHAEMIC 4 0.0006
462 LUNG DISORDER 29 0.0006
463 VERTIGO 36 0.0006
464 ABNORMAL LOSS OF WEIGHT 4 0.0006
465 HYPERLIPIDAEMIA 7 0.0006
466 UPPER RESPIRATORY TRACT INFECTION 27 0.0006
467 RESPIRATION ABNORMAL 4 0.0006
468 PARANOIA 10 0.0006
469 PSYCHOLOGICAL TRAUMA 5 0.0006
470 GASTRIC ULCER 11 0.0006
471 DIPLOPIA 15 0.0006
472 HYSTERECTOMY 5 0.0006
473 MENTAL STATUS CHANGES 16 0.0006
474 HERPES ZOSTER 33 0.0006
475 LOCAL SWELLING 10 0.0006
476 INTENTIONAL PRODUCT USE ISSUE 50 0.0006
477 ERUCTATION 11 0.0006
478 DECREASED APPETITE 132 0.0006
479 RESPIRATORY TRACT CONGESTION 9 0.0006
480 PERIPHERAL SWELLING 87 0.0006
481 HAND FRACTURE 4 0.0006
482 HYPOTHYROIDISM 18 0.0006
483 ORAL HERPES 11 0.0006
484 DIVERTICULUM 4 0.0006
485 TOOTH EXTRACTION 7 0.0006
486 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 27 0.0006
487 AGGRESSION 28 0.0006
488 HYPERSOMNIA 16 0.0006
489 OEDEMA PERIPHERAL 68 0.0006
490 DRUG DOSE OMISSION 92 0.0006
491 BACK PAIN 129 0.0006
492 PRURITUS GENERALISED 12 0.0006
493 GASTRIC DISORDER 19 0.0006
494 SKIN LACERATION 6 0.0006
495 HYPOKINESIA 8 0.0006
496 DRUG EFFECT INCOMPLETE 20 0.0006
497 DEPRESSED MOOD 29 0.0005
498 DYSSTASIA 16 0.0005
499 UTERINE LEIOMYOMA 4 0.0005
500 CHILLS 64 0.0005
501 ASTHENOPIA 3 0.0005
502 INCREASED TENDENCY TO BRUISE 5 0.0005
503 MOBILITY DECREASED 39 0.0005
504 DENTAL CARIES 6 0.0005
505 FEEDING DISORDER 11 0.0005
506 UROSEPSIS 5 0.0005
507 HYPOPHOSPHATAEMIA 4 0.0005
508 ARTHROPOD BITE 4 0.0005
509 JOINT SWELLING 65 0.0005
510 DRUG EFFECT DECREASED 29 0.0005
511 NEPHROPATHY 5 0.0005
512 RIB FRACTURE 11 0.0005
513 RENAL FAILURE 71 0.0005
514 SEDATION 14 0.0005
515 TRANSIENT ISCHAEMIC ATTACK 18 0.0005
516 EYE INFECTION 6 0.0005
517 HYPOAESTHESIA ORAL 8 0.0005
518 INTESTINAL OBSTRUCTION 20 0.0005
519 BLOOD SODIUM DECREASED 10 0.0005
520 DISORIENTATION 21 0.0005
521 PAIN IN EXTREMITY 156 0.0005
522 SURGERY 31 0.0005
523 MENTAL DISORDER 23 0.0005
524 SOMNOLENCE 106 0.0005
525 PRODUCT PACKAGING ISSUE 5 0.0005
526 DRUG INTERACTION 83 0.0005
527 INSURANCE ISSUE 8 0.0005
528 KNEE ARTHROPLASTY 11 0.0005
529 ARTHRALGIA 217 0.0005
530 PROCEDURAL COMPLICATION 4 0.0005
531 WHITE BLOOD CELL COUNT INCREASED 20 0.0005
532 DYSKINESIA 21 0.0005
533 OEDEMA 28 0.0005
534 PRODUCT QUALITY ISSUE 70 0.0005
535 STAPHYLOCOCCAL INFECTION 17 0.0005
536 LOSS OF CONSCIOUSNESS 66 0.0005
537 ALOPECIA 101 0.0005
538 PELVIC FRACTURE 4 0.0005
539 PARKINSONISM 5 0.0005
540 SPINAL PAIN 6 0.0005
541 MULTIPLE ALLERGIES 4 0.0005
542 THERAPY CHANGE 5 0.0005
543 DISCOMFORT 31 0.0005
544 FAECES DISCOLOURED 11 0.0005
545 FURUNCLE 4 0.0005
546 NASAL DISCOMFORT 4 0.0005
547 BLOOD ALBUMIN DECREASED 4 0.0005
548 ULCER 8 0.0005
549 HUNGER 7 0.0005
550 RASH 219 0.0005
551 RASH GENERALISED 13 0.0005
552 COORDINATION ABNORMAL 7 0.0005
553 GASTROENTERITIS VIRAL 9 0.0005
554 INFLUENZA LIKE ILLNESS 41 0.0005
555 WEIGHT DECREASED 139 0.0005
556 ASTHENIA 187 0.0005
557 SKIN REACTION 7 0.0005
558 OROPHARYNGEAL PAIN 46 0.0005
559 TOOTH DISORDER 11 0.0005
560 ADRENAL INSUFFICIENCY 6 0.0005
561 EYELID PTOSIS 5 0.0005
562 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 35 0.0005
563 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 35 0.0005
564 RASH PAPULAR 11 0.0005
565 SLUGGISHNESS 5 0.0005
566 ADVERSE EVENT 45 0.0005
567 CARDIOMEGALY 6 0.0005
568 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
569 VENTRICULAR TACHYCARDIA 8 0.0005
570 HEPATIC STEATOSIS 9 0.0005
571 DRY EYE 24 0.0005
572 SWOLLEN TONGUE 15 0.0005
573 COAGULOPATHY 8 0.0005
574 MALAISE 210 0.0005
575 DRUG WITHDRAWAL SYNDROME 42 0.0005
576 DYSARTHRIA 18 0.0005
577 INFLUENZA 53 0.0005
578 SCRATCH 5 0.0005
579 COGNITIVE DISORDER 22 0.0005
580 INADEQUATE ANALGESIA 4 0.0005
581 EATING DISORDER 10 0.0005
582 CHEST DISCOMFORT 48 0.0005
583 FALL 156 0.0005
584 SKIN ULCER 12 0.0005
585 HAEMATOMA 12 0.0005
586 CARDIAC MURMUR 4 0.0005
587 ECONOMIC PROBLEM 7 0.0005
588 VISUAL IMPAIRMENT 57 0.0005
589 SPEECH DISORDER 24 0.0005
590 ANHEDONIA 12 0.0005
591 POLLAKIURIA 19 0.0005
592 DEVICE RELATED INFECTION 7 0.0005
593 SINUS DISORDER 9 0.0005
594 INJECTION SITE NODULE 5 0.0005
595 IMMUNOSUPPRESSION 4 0.0005
596 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
597 LYMPHADENOPATHY 16 0.0005
598 ASTHMA 51 0.0005
599 LIVER DISORDER 20 0.0005
600 FUNGAL INFECTION 15 0.0004
601 SKIN DISORDER 15 0.0004
602 PRODUCT ADHESION ISSUE 16 0.0004
603 HYPERSENSITIVITY 83 0.0004
604 BREAST MASS 3 0.0004
605 SKIN INFECTION 5 0.0004
606 FATIGUE 347 0.0004
607 PRODUCT USE COMPLAINT 7 0.0004
608 PRODUCT DOSE OMISSION 29 0.0004
609 THROAT TIGHTNESS 12 0.0004
610 CHROMATURIA 10 0.0004
611 HEART RATE IRREGULAR 10 0.0004
612 MITRAL VALVE INCOMPETENCE 5 0.0004
613 SEIZURE 51 0.0004
614 MYALGIA 75 0.0004
615 CONDITION AGGRAVATED 134 0.0004
616 BONE DISORDER 8 0.0004
617 INTERNAL HAEMORRHAGE 5 0.0004
618 ECCHYMOSIS 3 0.0004
619 INJECTION SITE WARMTH 9 0.0004
620 CATARACT 26 0.0004
621 APPLICATION SITE RASH 6 0.0004
622 BLOOD THYROID STIMULATING HORMONE INCREASED 4 0.0004
623 ORAL DISCOMFORT 6 0.0004
624 PERSONALITY CHANGE 4 0.0004
625 ABNORMAL BEHAVIOUR 17 0.0004
626 DYSPEPSIA 42 0.0004
627 SEXUAL DYSFUNCTION 5 0.0004
628 GAIT DISTURBANCE 81 0.0004
629 ADVERSE DRUG REACTION 38 0.0004
630 TREATMENT FAILURE 35 0.0004
631 SPINAL DISORDER 4 0.0004
632 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
633 SPUTUM DISCOLOURED 4 0.0004
634 BLOOD URINE PRESENT 8 0.0004
635 MUSCULOSKELETAL DISORDER 8 0.0004
636 MYOCLONUS 5 0.0004
637 MACULAR DEGENERATION 5 0.0004
638 INCREASED APPETITE 8 0.0004
639 IMPAIRED QUALITY OF LIFE 6 0.0004
640 DRUG PRESCRIBING ERROR 8 0.0004
641 PARAESTHESIA ORAL 6 0.0004
642 NEPHROLITHIASIS 19 0.0004
643 ATELECTASIS 4 0.0004
644 PRESYNCOPE 10 0.0004
645 FEAR 11 0.0004
646 RENAL TUBULAR NECROSIS 4 0.0004
647 BLINDNESS TRANSIENT 3 0.0004
648 MUSCULOSKELETAL DISCOMFORT 7 0.0004
649 KNEE OPERATION 4 0.0004
650 PSYCHOTIC DISORDER 12 0.0004
651 SMALL INTESTINAL OBSTRUCTION 5 0.0004
652 CARDIOMYOPATHY 6 0.0004
653 PRURITUS 156 0.0004
654 CEREBRAL DISORDER 3 0.0004
655 TENDON RUPTURE 5 0.0004
656 LIMB INJURY 11 0.0004
657 STEVENS-JOHNSON SYNDROME 9 0.0004
658 HAEMATOCRIT DECREASED 8 0.0004
659 CYST 5 0.0004
660 IMMUNODEFICIENCY 6 0.0004
661 ABDOMINAL DISTENSION 42 0.0004
662 HAIR COLOUR CHANGES 5 0.0004
663 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 22 0.0004
664 INTENTIONAL PRODUCT MISUSE 35 0.0004
665 PREGNANCY 8 0.0004
666 NEUROPATHY PERIPHERAL 38 0.0004
667 AMENORRHOEA 7 0.0004
668 DERMATITIS ALLERGIC 5 0.0004
669 PRODUCT USE IN UNAPPROVED INDICATION 98 0.0004
670 VAGINAL DISCHARGE 4 0.0004
671 MUSCLE ATROPHY 5 0.0004
672 AORTIC ANEURYSM 3 0.0004
673 FLUID RETENTION 20 0.0004
674 TOOTH ABSCESS 4 0.0004
675 MATERNAL EXPOSURE DURING PREGNANCY 35 0.0004
676 ACIDOSIS 3 0.0004
677 ACUTE KIDNEY INJURY 60 0.0004
678 THIRST 7 0.0004
679 SKIN DISCOLOURATION 18 0.0004
680 VAGINAL HAEMORRHAGE 17 0.0004
681 DISSOCIATION 3 0.0004
682 INTRAOCULAR PRESSURE INCREASED 5 0.0004
683 HEPATITIS 10 0.0004
684 VIRAL INFECTION 13 0.0004
685 DYSGEUSIA 29 0.0004
686 EYE PAIN 22 0.0004
687 INITIAL INSOMNIA 4 0.0004
688 EAR DISCOMFORT 4 0.0004
689 TENDONITIS 6 0.0004
690 URINARY TRACT INFECTION 66 0.0004
691 POOR VENOUS ACCESS 4 0.0004
692 VENTRICULAR EXTRASYSTOLES 4 0.0004
693 NASOPHARYNGITIS 71 0.0004
694 EYE DISCHARGE 4 0.0004
695 SWELLING FACE 25 0.0004
696 TRANSFUSION 4 0.0004
697 GASTRITIS 10 0.0004
698 GASTROINTESTINAL DISORDER 34 0.0004
699 ANKYLOSING SPONDYLITIS 5 0.0004
700 TOOTH INFECTION 5 0.0004
701 ILL-DEFINED DISORDER 23 0.0004
702 INFUSION RELATED REACTION 25 0.0004
703 CYSTITIS 12 0.0004
704 BACTERIAL INFECTION 7 0.0004
705 GENERAL PHYSICAL HEALTH DETERIORATION 43 0.0004
706 RHINORRHOEA 24 0.0004
707 FREQUENT BOWEL MOVEMENTS 10 0.0004
708 COLITIS 14 0.0004
709 ALTERED STATE OF CONSCIOUSNESS 8 0.0004
710 RASH PRURITIC 20 0.0004
711 GINGIVAL BLEEDING 5 0.0004
712 BLOOD POTASSIUM DECREASED 11 0.0004
713 MULTIPLE SCLEROSIS RELAPSE 25 0.0004
714 DRUG INEFFECTIVE 480 0.0004
715 GASTROINTESTINAL PAIN 4 0.0004
716 TOOTH FRACTURE 4 0.0004
717 ELECTROCARDIOGRAM QT PROLONGED 13 0.0004
718 PANCREATITIS 19 0.0004
719 INJECTION SITE RASH 11 0.0004
720 BLOOD UREA INCREASED 6 0.0004
721 INJECTION SITE PRURITUS 24 0.0004
722 SKIN FISSURES 7 0.0004
723 ABDOMINAL PAIN 83 0.0004
724 THERAPY NON-RESPONDER 16 0.0004
725 PANCREATITIS ACUTE 8 0.0004
726 BLOOD TEST ABNORMAL 5 0.0004
727 BLOOD CALCIUM DECREASED 4 0.0004
728 CANDIDA INFECTION 6 0.0004
729 HYPONATRAEMIA 20 0.0004
730 FLATULENCE 20 0.0004
731 HYPOPHAGIA 9 0.0004
732 THERAPY CESSATION 18 0.0004
733 ERECTILE DYSFUNCTION 9 0.0004
734 EYE SWELLING 13 0.0003
735 PARALYSIS 5 0.0003
736 ANAPHYLACTIC SHOCK 9 0.0003
737 ANURIA 3 0.0003
738 DYSPHAGIA 33 0.0003
739 DYSPNOEA EXERTIONAL 13 0.0003
740 MADAROSIS 4 0.0003
741 ORTHOSTATIC HYPOTENSION 6 0.0003
742 RASH MACULAR 12 0.0003
743 BLOOD CALCIUM INCREASED 3 0.0003
744 LABORATORY TEST ABNORMAL 10 0.0003
745 ASPARTATE AMINOTRANSFERASE INCREASED 18 0.0003
746 DEHYDRATION 45 0.0003
747 SKIN HAEMORRHAGE 5 0.0003
748 NEUROLEPTIC MALIGNANT SYNDROME 4 0.0003
749 PRODUCT USE ISSUE 63 0.0003
750 EYE DISORDER 11 0.0003
751 THYROID CANCER 4 0.0003
752 SKIN EXFOLIATION 28 0.0003
753 BLOOD PRESSURE DECREASED 22 0.0003
754 PELVIC PAIN 6 0.0003
755 LETHARGY 19 0.0003
756 LOWER RESPIRATORY TRACT INFECTION 15 0.0003
757 NOCTURIA 4 0.0003
758 DRUG DISPENSING ERROR 5 0.0003
759 THYROID DISORDER 5 0.0003
760 INJECTION SITE EXTRAVASATION 4 0.0003
761 LYMPHOMA 5 0.0003
762 DYSPNOEA 183 0.0003
763 MUSCULOSKELETAL CHEST PAIN 5 0.0003
764 RENAL DISORDER 15 0.0003
765 ILEUS 4 0.0003
766 ERYTHEMA MULTIFORME 3 0.0003
767 DRUG-INDUCED LIVER INJURY 10 0.0003
768 POISONING 4 0.0003
769 CELLULITIS 16 0.0003
770 DIARRHOEA 204 0.0003
771 OFF LABEL USE 276 0.0003
772 HALLUCINATION, AUDITORY 5 0.0003
773 ANGINA PECTORIS 9 0.0003
774 INJECTION SITE BRUISING 25 0.0003
775 SNEEZING 7 0.0003
776 UNRESPONSIVE TO STIMULI 8 0.0003
777 ALANINE AMINOTRANSFERASE INCREASED 19 0.0003
778 DYSTONIA 6 0.0003
779 BLOOD POTASSIUM INCREASED 5 0.0003
780 DYSPHONIA 18 0.0003
781 PSORIASIS 40 0.0003
782 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
783 APPLICATION SITE ERYTHEMA 8 0.0003
784 INJECTION SITE REACTION 21 0.0003
785 INCORRECT PRODUCT STORAGE 4 0.0003
786 MULTIPLE FRACTURES 5 0.0003
787 PERICARDIAL EFFUSION 7 0.0003
788 RECTAL HAEMORRHAGE 13 0.0003
789 DIABETES MELLITUS 23 0.0003
790 UPPER LIMB FRACTURE 6 0.0003
791 PAIN OF SKIN 8 0.0003
792 FACE OEDEMA 5 0.0003
793 SINUS CONGESTION 4 0.0003
794 CIRCULATORY COLLAPSE 5 0.0003
795 CORONARY ARTERY OCCLUSION 4 0.0003
796 SKIN LESION 8 0.0003
797 BLOOD PRESSURE FLUCTUATION 7 0.0003
798 LIMB DISCOMFORT 9 0.0003
799 BONE PAIN 17 0.0003
800 NASAL CONGESTION 17 0.0003
801 DIVERTICULITIS 8 0.0003
802 RHABDOMYOLYSIS 12 0.0003
803 INJECTION SITE PAIN 88 0.0003
804 DEVICE MALFUNCTION 20 0.0003
805 TARDIVE DYSKINESIA 8 0.0003
806 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
807 PAIN IN JAW 8 0.0003
808 ERYTHEMA 58 0.0003
809 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
810 BREAST PAIN 3 0.0003
811 INTENTIONAL DOSE OMISSION 8 0.0003
812 PYREXIA 97 0.0003
813 HYPOACUSIS 12 0.0003
814 SKIN CANCER 6 0.0003
815 HAEMORRHAGE 29 0.0003
816 INFECTION 40 0.0003
817 LEUKOCYTOSIS 5 0.0003
818 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
819 INJECTION SITE ERYTHEMA 34 0.0003
820 OCULAR HYPERAEMIA 13 0.0003
821 BLOOD GLUCOSE FLUCTUATION 3 0.0003
822 PULMONARY EMBOLISM 26 0.0003
823 COMA 13 0.0003
824 MULTIPLE SCLEROSIS 13 0.0003
825 BLOOD GLUCOSE DECREASED 13 0.0003
826 INJECTION SITE MASS 10 0.0003
827 MEDICATION ERROR 15 0.0003
828 SYNCOPE 27 0.0003
829 RASH MACULO-PAPULAR 6 0.0003
830 PNEUMONIA 87 0.0003
831 PULMONARY MASS 4 0.0003
832 HYPOGLYCAEMIA 13 0.0003
833 THROAT IRRITATION 12 0.0003
834 THERAPEUTIC RESPONSE DECREASED 16 0.0003
835 SHOCK 6 0.0003
836 HERNIA 5 0.0003
837 DELUSION 4 0.0003
838 CARDIAC DISORDER 24 0.0003
839 BASAL CELL CARCINOMA 4 0.0003
840 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
841 NERVOUS SYSTEM DISORDER 8 0.0003
842 CYANOSIS 4 0.0003
843 ARRHYTHMIA 12 0.0003
844 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
845 ILLNESS 26 0.0003
846 PROCEDURAL PAIN 7 0.0003
847 ACCIDENT 3 0.0003
848 ABSCESS 4 0.0003
849 INTENTIONAL OVERDOSE 16 0.0002
850 INJECTION SITE SWELLING 19 0.0002
851 PRODUCT PHYSICAL ISSUE 5 0.0002
852 BODY TEMPERATURE INCREASED 5 0.0002
853 VISUAL ACUITY REDUCED 8 0.0002
854 EXPIRED PRODUCT ADMINISTERED 8 0.0002
855 EPISTAXIS 18 0.0002
856 EYE PRURITUS 8 0.0002
857 RENAL IMPAIRMENT 20 0.0002
858 THERAPY INTERRUPTED 17 0.0002
859 HALLUCINATION, VISUAL 5 0.0002
860 HEMIPARESIS 4 0.0002
861 RENAL FAILURE ACUTE 10 0.0002
862 HAEMATOCHEZIA 13 0.0002
863 HAEMATURIA 8 0.0002
864 BLOOD GLUCOSE INCREASED 44 0.0002
865 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
866 RESPIRATORY TRACT INFECTION 6 0.0002
867 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12 0.0002
868 ADVERSE REACTION 3 0.0002
869 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
870 EYE HAEMORRHAGE 3 0.0002
871 COUGH 63 0.0002
872 GALLBLADDER DISORDER 4 0.0002
873 GOUT 4 0.0002
874 TOOTHACHE 4 0.0002
875 APPLICATION SITE PRURITUS 5 0.0002
876 AKATHISIA 3 0.0002
877 HYPOTENSION 44 0.0002
878 TREATMENT NONCOMPLIANCE 12 0.0002
879 HYPOKALAEMIA 10 0.0002
880 PLEURAL EFFUSION 13 0.0002
881 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
882 BLINDNESS UNILATERAL 3 0.0002
883 THROMBOSIS 17 0.0002
884 RED BLOOD CELL COUNT DECREASED 6 0.0002
885 RASH ERYTHEMATOUS 10 0.0002
886 PRODUCT SUBSTITUTION ISSUE 12 0.0002
887 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 42 0.0002
888 LOCALISED INFECTION 5 0.0002
889 INJECTION SITE URTICARIA 5 0.0002
890 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
891 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
892 SPINAL FRACTURE 4 0.0002
893 FULL BLOOD COUNT DECREASED 4 0.0002
894 DRUG ADMINISTRATION ERROR 6 0.0002
895 HOSPITALISATION 30 0.0002
896 ATRIAL FIBRILLATION 19 0.0002
897 ANAEMIA 37 0.0002
898 WHITE BLOOD CELL COUNT DECREASED 21 0.0002
899 BREAST CANCER 18 0.0002
900 GASTROINTESTINAL HAEMORRHAGE 16 0.0002
901 CARDIO-RESPIRATORY ARREST 8 0.0002
902 INTENTIONAL DRUG MISUSE 4 0.0002
903 DERMATITIS 4 0.0002
904 MOUTH ULCERATION 4 0.0002
905 DISEASE RECURRENCE 9 0.0002
906 CEREBROVASCULAR ACCIDENT 32 0.0002
907 CARDIAC FAILURE CONGESTIVE 15 0.0002
908 HIP FRACTURE 6 0.0002
909 JAUNDICE 5 0.0002
910 PRODUCT DISPENSING ERROR 4 0.0002
911 CHOLELITHIASIS 6 0.0002
912 RESPIRATORY DISTRESS 5 0.0002
913 ANGIOEDEMA 8 0.0002
914 HEPATOTOXICITY 4 0.0002
915 COLITIS ULCERATIVE 8 0.0002
916 DEMENTIA 5 0.0002
917 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
918 INJECTION SITE HAEMORRHAGE 14 0.0002
919 EMOTIONAL DISTRESS 21 0.0002
920 ECZEMA 9 0.0002
921 MYOCARDIAL INFARCTION 30 0.0002
922 LIVER FUNCTION TEST ABNORMAL 5 0.0002
923 BLINDNESS 7 0.0002
924 NEEDLE ISSUE 5 0.0002
925 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
926 COVID-19 30 0.0002
927 ACUTE MYOCARDIAL INFARCTION 5 0.0002
928 INCORRECT DOSE ADMINISTERED 38 0.0002
929 ACCIDENTAL OVERDOSE 6 0.0002
930 EXTRAPYRAMIDAL DISORDER 4 0.0002
931 EXPOSURE DURING PREGNANCY 10 0.0002
932 LEUKOPENIA 8 0.0002
933 PRODUCT DOSE OMISSION ISSUE 47 0.0002
934 BONE DENSITY DECREASED 5 0.0002
935 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
936 ACUTE RESPIRATORY FAILURE 3 0.0002
937 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 28 0.0002
938 BLOOD CREATININE INCREASED 10 0.0002
939 DEAFNESS 4 0.0002
940 OSTEONECROSIS 5 0.0002
941 DISEASE PROGRESSION 18 0.0002
942 UNDERDOSE 11 0.0002
943 OVERDOSE 32 0.0001
944 HAEMOGLOBIN DECREASED 15 0.0001
945 HEART RATE DECREASED 5 0.0001
946 EYE IRRITATION 8 0.0001
947 APPLICATION SITE PAIN 3 0.0001
948 DRY SKIN 18 0.0001
949 CARDIAC ARREST 11 0.0001
950 ANAPHYLACTIC REACTION 7 0.0001
951 PRODUCTIVE COUGH 6 0.0001
952 SEPSIS 14 0.0001
953 DIABETIC KETOACIDOSIS 3 0.0001
954 OXYGEN SATURATION DECREASED 7 0.0001
955 AGEUSIA 3 0.0001
956 COMPLETED SUICIDE 10 0.0001
957 ABDOMINAL PAIN LOWER 3 0.0001
958 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
959 CARDIOVASCULAR DISORDER 3 0.0001
960 DERMATITIS ATOPIC 6 0.0001
961 BREAST CANCER FEMALE 3 0.0001
962 CEREBRAL HAEMORRHAGE 4 0.0001
963 PULMONARY OEDEMA 5 0.0001
964 DEEP VEIN THROMBOSIS 7 0.0001
965 HEPATIC FUNCTION ABNORMAL 4 0.0001
966 ACNE 8 0.0001
967 NEOPLASM MALIGNANT 7 0.0001
968 NO ADVERSE EVENT 19 0.0001
969 DEVICE ISSUE 9 0.0001
970 DRUG DEPENDENCE 16 0.0001
971 EXTRA DOSE ADMINISTERED 4 0.0001
972 NEUTROPHIL COUNT DECREASED 4 0.0001
973 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
974 TOXICITY TO VARIOUS AGENTS 16 0.0001
975 BRADYCARDIA 5 0.0001
976 DEVICE LEAKAGE 4 0.0001
977 SKIN BURNING SENSATION 6 0.0001
978 DEVICE DIFFICULT TO USE 5 0.0001
979 PLATELET COUNT DECREASED 8 0.0001
980 ABORTION SPONTANEOUS 3 0.0001
981 CARDIAC FAILURE 6 0.0001
982 FOETAL EXPOSURE DURING PREGNANCY 6 0.0001
983 DEVICE DISLOCATION 3 0.0001
984 RESPIRATORY FAILURE 5 0.0001
985 THROMBOCYTOPENIA 7 0.0001
986 PRODUCT STORAGE ERROR 5 0.0001
987 DEPENDENCE 3 0.0001
988 DEATH 43 0.0000
989 DRUG ABUSE 3 0.0000